COGT
Cogent Biosciences, Inc.Company with tickers: COGT
CIK
1622229
CUSIP
19240Q201
Shares Outstanding
170,868,004
13F Activity (30d)
193 filings
188 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-09 | Ros Matthew |
Director | Award | 17,901 |
| 2026-06-09 | Ferrante Karen Jean |
Director | Award | 17,901 |
| 2026-06-09 | Morris Arlene |
Director | Award | 17,901 |
| 2026-06-09 | Harwin Peter Evan |
Director | Award | 17,901 |
| 2026-06-09 | CAIN CHRISTOPHER W. |
Director | Award | 17,901 |
| 2026-06-09 | Shegog Todd |
Director | Award | 17,901 |
| 2026-05-19 | Robbins Andrew R |
Director, President and CEO | Gift | 160,000 |
| 2026-05-19 | Robbins Andrew R |
Director, President and CEO | Gift | 160,000 |
| 2026-04-01 | Ferrante Karen Jean |
Director | Award | 686 |
| 2026-03-31 | Fairmount Funds Management LLC |
Director | Other | 7,000,000 |
| 2026-03-31 | Fairmount Funds Management LLC |
Director | Other | 28,000 |
| 2026-03-31 | Fairmount Funds Management LLC |
Director | Sell | 7,000,000 |
| 2026-01-22 | Fairmount Funds Management LLC |
Director | Sell | 3,500,000 |
| 2026-01-22 | Fairmount Funds Management LLC |
Director | Other | 67,414 |
| 2026-01-01 | Ferrante Karen Jean |
Director | Award | 643 |
| 2025-12-26 | Kearns Evan |
Chief Legal Officer | Sell | 65,000 |
| 2025-12-26 | Sachs Jessica |
Chief Medical Officer | Sell | 82,642 |
| 2025-12-26 | Robinson John Edward |
Chief Scientific Officer | Sell | 90,000 |
| 2025-12-26 | Green John L. |
Chief Financial Officer | Sell | 77,000 |
| 2025-12-17 | Kearns Evan |
Chief Legal Officer | Award | 260,000 |
| 2025-12-17 | Robbins Andrew R |
Director, President and CEO | Award | 840,000 |
| 2025-12-17 | Green John L. |
Chief Financial Officer | Award | 65,000 |
| 2025-12-17 | Kearns Evan |
Chief Legal Officer | Tax | 125,602 |
| 2025-12-17 | Pinnow Cole |
Chief Commercial Officer | Tax | 94,800 |
| 2025-12-17 | Robinson John Edward |
Chief Scientific Officer | Award | 65,000 |
| 2025-12-17 | Sachs Jessica |
Chief Medical Officer | Award | 320,000 |
| 2025-12-17 | Sachs Jessica |
Chief Medical Officer | Award | 65,000 |
| 2025-12-17 | Kearns Evan |
Chief Legal Officer | Award | 55,000 |
| 2025-12-17 | Pinnow Cole |
Chief Commercial Officer | Award | 65,000 |
| 2025-12-17 | Kearns Evan |
Chief Legal Officer | Award | 40,000 |
| 2025-12-17 | Robinson John Edward |
Chief Scientific Officer | Tax | 139,998 |
| 2025-12-17 | Pinnow Cole |
Chief Commercial Officer | Award | 214,000 |
| 2025-12-17 | Robbins Andrew R |
Director, President and CEO | Tax | 367,497 |
| 2025-12-17 | Green John L. |
Chief Financial Officer | Award | 300,000 |
| 2025-12-17 | Robbins Andrew R |
Director, President and CEO | Award | 185,000 |
| 2025-12-17 | Robbins Andrew R |
Director, President and CEO | Award | 245,000 |
| 2025-12-17 | Robinson John Edward |
Chief Scientific Officer | Award | 50,000 |
| 2025-12-17 | Robinson John Edward |
Chief Scientific Officer | Award | 320,000 |
| 2025-12-17 | Pinnow Cole |
Chief Commercial Officer | Award | 50,000 |
| 2025-12-17 | Sachs Jessica |
Chief Medical Officer | Tax | 154,716 |
| 2025-12-17 | Sachs Jessica |
Chief Medical Officer | Award | 50,000 |
| 2025-12-17 | Green John L. |
Chief Financial Officer | Tax | 145,007 |
| 2025-12-17 | Green John L. |
Chief Financial Officer | Award | 50,000 |
| 2025-10-01 | Ferrante Karen Jean |
Director | Award | 1,642 |
| 2025-07-10 | Fairmount Funds Management LLC |
Director | Buy | 2,777,777 |
| 2025-07-01 | Ferrante Karen Jean |
Director | Award | 3,314 |
| 2025-06-04 | Morris Arlene |
Director | Award | 44,700 |
| 2025-06-04 | Ros Matthew |
Director | Award | 44,700 |
| 2025-06-04 | CAIN CHRISTOPHER W. |
Director | Award | 44,700 |
| 2025-06-04 | Harwin Peter Evan |
Director | Award | 44,700 |
Showing 1–50 of 235 transactions